Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prenatal dexamethasone exposure and neurocognitive development in children at risk of congenital adrenal hyperplasia
2015-003996-32Phase 4Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Dec 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexamethasone in congenital adrenal hyperplasia (CAH) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: IQ assessment (four index). Started Dec 2015; status: completed.
02
Drugs
dexamethasone
03
Conditions
congenital adrenal hyperplasia (CAH)
Beyond the preview
Go deeper on 2015-003996-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003996-32.